Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
about
Molecular prognostic prediction in liver cirrhosisThe role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinomaInsights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic interventionFuture of liver disease in the era of direct acting antivirals for the treatment of hepatitis CHepatitis C virus-induced hepatocellular carcinomaPersonalized management of hepatocellular carcinoma based on molecular information: future prospects.Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected HepatocytesHepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.Clinicopathological indices to predict hepatocellular carcinoma molecular classificationHow Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study.The role of viral co-infection in HIV-associated non-AIDS-related cancersHepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye.Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma.Development and evaluation of a novel score for prediction of large oesophageal varices in patients with hepatitis c virus-induced liver cirrhosis.PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma.Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV.Circulating microRNAs for early detection of hepatitis B-related hepatocellular carcinoma.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.Expression Levels of the Uridine-Cytidine Kinase Like-1 Protein As a Novel Prognostic Factor for Hepatitis C Virus-Associated Hepatocellular Carcinomas.Low-Grade Dysplastic Nodules Revealed as the Tipping Point during Multistep Hepatocarcinogenesis by Dynamic Network Biomarkers.Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection.Genetic variations in NF-κB were associated with the susceptibility to hepatitis C virus infection among Chinese high-risk population.High serum microRNA-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients.Pathways of topological rank analysis (PoTRA): a novel method to detect pathways involved in hepatocellular carcinoma.Calcium channel α2δ1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma.Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C.The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia.Host-targeting therapies for hepatitis C virus infection: current developments and future applications.Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus InfectionTranscriptional Regulatory Networks in Hepatitis C Virus-induced Hepatocellular CarcinomaHepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief reviewUpdate in global trends and aetiology of hepatocellular carcinoma
P2860
Q26784251-7B26D205-7868-4B33-978D-B99B66866D28Q28066407-3E32A4A5-2E00-409C-90FF-5D44D276A5F9Q28080281-70502D8F-FB21-443A-9649-844D1E33C70BQ30235178-6DC840C0-F0C5-4F76-B0EA-054E56F6D4D5Q35824057-87F59C3D-293A-4CB2-8541-8B9C98F1A327Q35881575-17CA9C1C-1F47-45D8-B1A9-42C0D61DA6AAQ36281852-D95E081D-9A11-4B2E-8762-C6597896F056Q36306768-222DDB0B-79E6-4B36-B15D-4BB4C628D0EFQ36359814-710ECA20-488C-413A-8B2C-D72516F38120Q36854662-B2C29163-B016-41E5-8AC8-BA4E8F376971Q36960884-827E2271-724B-4239-88FC-EA9AFAD13343Q37073281-1D85B83E-992D-477A-8771-F974D71B93E5Q38522791-6AB1269F-EDE3-4855-89C6-AE5093B6B69AQ38631740-0FDBDA48-5568-4246-81E5-CFB8C942DD57Q38726399-25BF668B-3544-463C-B33F-6640226154E9Q38848401-0FA071CF-D1B4-4BE0-9F90-0B3C01392A22Q38980732-7421913C-6AB1-4E73-88F8-50769E64DDE9Q38999576-BB96F5F0-4AAF-468C-B69A-FC407EB8313BQ39377876-85467511-3540-4A57-8AC8-9B448A48B900Q40509021-C711BC06-5102-486E-8330-7D3F69C81D37Q41822877-C720649D-374C-4AC5-98A9-D5854C6D83D0Q41921861-F140EBE1-A99F-4F06-B7E1-8CF6467AEAD3Q42137309-0204A833-3D13-4E38-B203-ED7466794509Q45325263-40E90505-7F68-4772-A8E5-2815235603D0Q45378146-2BB4E19C-66E9-4FBD-BB34-61F72F6C4D48Q47550120-975775D0-0E47-4DE5-93B9-14655229B2F4Q47557031-55875B1B-78E0-4852-87C2-0B8B84E0E139Q51061150-229E1A67-02EA-43A5-A153-D889214B4E5DQ52318559-6F91138C-4502-481C-A5F9-3CB70050F034Q52652985-15913C1E-1FB2-4EA6-854F-00DF19D2DBD6Q54217563-283E9F5C-661F-4CF4-90A5-B8B794A5BBD9Q55130392-D13C9633-2D77-4572-8367-3A2544B47C95Q55280981-5F32205A-558F-4013-B1A6-A20AF73B50A0Q57067833-8A309FC4-05BD-4E5D-8789-C558F55B3C1EQ57152054-BA475ECF-E313-42F6-90E2-330A505429EDQ57491226-F93D099F-4815-46E4-A59F-356E2D97267EQ59136659-945DE930-C56B-4A50-81C4-CF5D11DAF07A
P2860
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
@ast
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
@en
type
label
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
@ast
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
@en
prefLabel
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
@ast
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
@en
P2093
P2860
P1476
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
@en
P2093
Bryan C Fuchs
Nabeel Bardeesy
Thomas F Baumert
Yujin Hoshida
P2860
P304
P356
10.1016/J.JHEP.2014.07.010
P433
P577
2014-11-03T00:00:00Z